← Back to Search

Motivational Interviewing for STI Screening

N/A
Waitlist Available
Led By Akshay Sharma, PhD
Research Sponsored by University of Michigan
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Individual self-reports having been diagnosed with HIV in the eligibility screener
Individual self-reports having any kind of condomless sex (e.g., oral, anal) with ≥2 men in the past year in the eligibility screener
Must not have
Individual self-reports not being ≥18 years of age in the eligibility screener
Individual self-reports not identifying as a man (regardless of sex assigned at birth) in the eligibility screener
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 32 weeks after participants complete the baseline survey
Awards & highlights
No Placebo-Only Group

Summary

This trial will investigate if gay/bi men w/ HIV are willing to collect & return bacterial STI specimens for testing when combined with live AV conferencing support, to prevent health complications & reduce transmissions.

Who is the study for?
The Zenyth trial is for gay and bisexual men over 18 years old living with HIV in the US, who've had condomless sex with at least two men in the past year. Participants must be willing to self-collect samples for STI testing and engage in motivational interviewing via live audio/video conferencing.
What is being tested?
This study tests if motivational interviewing through telehealth can encourage these individuals to self-collect specimens for bacterial STI screening, aiming to improve timely diagnosis and treatment of infections like syphilis, chlamydia, and gonorrhea.
What are the potential side effects?
There are no direct medical side effects from participating as it involves non-invasive specimen collection and counseling sessions. However, participants may experience discomfort or emotional distress during sample collection or discussions.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have been diagnosed with HIV.
Select...
I've had unprotected sex with 2 or more men in the last year.
Select...
I am 18 years old or older.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I am under 18 years old.
Select...
I do not identify as a man.
Select...
I am not old enough to consent to research in my state.
Select...
I have not had unprotected sex with 2 or more men in the past year.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 32 weeks after participants complete the baseline survey
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 32 weeks after participants complete the baseline survey for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Interventionist perceptions
Likelihood of recommending the intervention to friends or sex partners
Overall intervention satisfaction
+2 more
Secondary study objectives
Improvement in STI-related knowledge
Improvement in self-efficacy for specimen self-collection
Likelihood of testing for bacterial STIs at least annually

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Telehealth interventionExperimental Treatment1 Intervention
Participants will receive an MI-based telehealth intervention for bacterial STI screening.

Find a Location

Who is running the clinical trial?

National Institutes of Health (NIH)NIH
2,811 Previous Clinical Trials
8,161,183 Total Patients Enrolled
University of MichiganLead Sponsor
1,852 Previous Clinical Trials
6,432,667 Total Patients Enrolled
National Institute of Allergy and Infectious Diseases (NIAID)NIH
3,319 Previous Clinical Trials
5,548,085 Total Patients Enrolled
~17 spots leftby Jan 2025